Farmaceutica R (RMAH) — Working Capital to Net Assets Ratio
Farmaceutica R (RMAH) has a Working Capital to Net Assets ratio of 42.5% as of December 2025. Working capital of RON34.43 Million (current assets of RON332.68 Million minus current liabilities of RON298.25 Million) is measured against net assets of RON80.99 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Farmaceutica R Working Capital to Net Assets (2020–2025)
This chart shows how Farmaceutica R's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 42.5%, reflecting working capital of RON34.43 Million against net assets of RON80.99 Million RON. See RMAH days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Farmaceutica R (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see RMAH stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (RON) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 42.5% | RON34.43 Million | RON80.99 Million | RON332.68 Million | RON298.25 Million | ▼ -0.1 pp |
| 2024 | 42.6% | RON31.91 Million | RON74.94 Million | RON327.80 Million | RON295.90 Million | ▲ +0.9 pp |
| 2023 | 41.7% | RON29.54 Million | RON70.86 Million | RON268.99 Million | RON239.45 Million | ▲ +2.1 pp |
| 2022 | 39.6% | RON27.12 Million | RON68.43 Million | RON241.72 Million | RON214.60 Million | ▼ -1.6 pp |
| 2021 | 41.2% | RON28.11 Million | RON68.22 Million | RON208.42 Million | RON180.30 Million | ▼ -11.2 pp |
| 2020 | 52.4% | RON41.82 Million | RON79.83 Million | RON204.21 Million | RON162.39 Million | — |